Neurotoxicity of commonly used antineoplastic agents (first of two parts).
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity*; D001921:Brain / Q000187:drug effects; D001927:Brain Diseases / Q000139:chemically induced; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D001523:Mental Disorders / Q000139:chemically induced; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D009420:Nervous System / Q000187:drug effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D009461:Neurologic Manifestations; D013577:Syndrome
D000970:Antineoplastic Agents; D001215:Asparaginase; D005472:Fluorouracil; D008727:Methotrexate